Navigation Links
Chem Rx to Present at Bear Stearns 20th Annual Healthcare Conference
Date:9/4/2007

NEW YORK, Sept. 4 /PRNewswire-FirstCall/ -- Paramount Acquisition Corp. (OTC Bulletin Board: PMQC, PMQCU, PMQCW), a special purpose acquisition corporation, announced today that Chem Rx, a major privately-owned long-term care pharmacy based in Long Beach, New York, will present at the Bear Stearns 20th Annual Healthcare Conference, which is being held on September 10 and 11 in New York, NY.

Steven Silva, Executive Vice President and Chief Operating Officer, Jerry Silva, President, Chief Executive Officer and Chairman, and Chuck Kelly, Chief Financial Officer, will present at the conference.

Date: Monday, September 10, 2007

Place: Grand Hyatt Hotel, New York, NY

Time: 4:00 PM ET

A live Webcast of Chem Rx's presentation at 4:00 PM ET will be available on the investor relations section of Chem Rx's website at: http://www.chemrx.net. A replay of the presentation will be available through Monday, September 24, 2007.

ABOUT CHEM RX

Founded more than 40 years ago, Chem Rx is a major, privately-owned long- term care pharmacy serving the New York City metropolitan area, as well as parts of New Jersey and Pennsylvania. Chem Rx's client base includes skilled nursing facilities and a wide range of other long-term care facilities. Chem Rx provides to more than 60,000 residents prescription and non-prescription drugs, intravenous medications, durable medical equipment items and surgical supplies. Chem Rx's website address is http://www.chemrx.net.

ABOUT PARAMOUNT ACQUISITION CORP.

Paramount Acquisition Corp. is a special purpose acquisition corporation that was formed for the specific purpose of effecting a merger, capital stock exchange, asset acquisition, or other similar business combination with an operating business in the healthcare industry. Paramount raised net proceeds of approximately $5
'/>"/>

SOURCE Paramount Acquisition Corp.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Surgeons Presented Guidelines For Postoperative Atrial Fibrillation
2. Researchers Present Ways To Reduce The Risk Of Dementia
3. Researchers Present Data Regarding The Efficiency Of Herbs
4. Critically Ill Patients More At Risk Of Infection If Glucose Is Present In Their Lung Secretions
5. Ovarian Cancer Presents ‘Target Symptoms’ Six Months Before Diagnosi
6. Drug Reactions First Present Themselves In The Mouth
7. Reminiscing Into The Past Makes You Dissatisfied With The Present
8. Living In The Past Indicates Dissatisfaction With Present
9. Movies Represent Coma In A Wrong Way
10. Onchocerciasis: Presentation And Treatment
11. Researchers Warn That Routine Physical Examination Could Miss Breech Presentation

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2009)...ers from the North Pole, Textsanta.net lets parent...a , North Pole, AK (PRWEB...cies at the North Pole Santa Claus has added SMS t...lobe informed of his Christmas progress at the Nor...tment have identified a large and growing percenta...
(Date:11/26/2009)...Ennis, P.A. is offering free nationwide confidenti... control pills who have suffered a Deep Vein Throm...ack or other related cardiac issues or had their G...800-856-6405 or go to the firm’s website at ...ase evaluation form. , (P...
(Date:11/25/2009)...swire/-SentinelleMedicalInc.,aleadingmanufacturero...algaryScientificInc.,aleadingproviderofsoftwareena...(TM)Breast4DAdvancedVisualizationsoftware. ,, T...tWebclientbasedmedicalimagingofferinginthemarket.C...-footprintaccess-requiringnosoftwaredownload,andru...
(Date:11/25/2009)...SNewswire/--TheBlackAIDSInstituterecentlyheldBoard...or2010. ,, ThenewBoardMembersareahighlydiverseg...ance,governmenthealthprograms,editorial,andbusines...fpersonalbackgroundsincludingbothheterosexualandga...epresentingmultipleagegroups. ,, (Photo: http:/...
(Date:11/25/2009)... statistically significant survival benefit from a...ceptor (ER)-positive tumors had high levels of pho...S118-P), according to a brief communication publis...onal Cancer Institute . , Approximately 50% of b...inical studies have shown that ER-alpha S118-P is ...
Breaking Medicine News(10 mins):Health News:Text Messages from Santa | Santa goes GREEN by going MOBILE for The March of Dimes 2Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 2Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 3Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 3Health News:Black AIDS Institute Announces 2010 Board Election Results 2
... human welfare, spread of infectious disease and f...atellite imagery in order to acquire the proper ba...in, the geography professor of Kansas State Univer... Doug Goodin uses remote sensing, in combinati...
...ate University, Doug Goodin, makes use of satellit...and cover //changes on human health and food secur...with other types of data, to monitor and predict t... Decisions about Human Welfare," which was sponsor...
... have been able to zero in (on) the modalities of ... and other types of diseases. // Clinical trials o...drug to reduce the potency of a key enzyme, in cha...nn Collegiate Professor of Chemistry at U-M. 'Ou...
...ecialist, NHS can be freed from its’ problems, if ..., are reconsidered before they are implemented. //...vatization plan may make matters worse for the dep...ce has deteriorated. Though plans of privatization...
... the launch of BARACLUDE? (entecavir) for the tre...llowing its approval by the Drug Controller Genera...ed for the treatment of chronic hepatitis B virus ...histologically active disease. BARACLUDE? is...
... are repeatedly failing to implement rules that wi...atients //from contaminated surgical instruments. ...keeping instruments in sets so they can be traced ...to see that surgical instruments were not contamin...
Other Medicine News:Health News:Ecological Changes affects human health, food security 2Health News:Satellite Imagery to monitor the Social Impact Of Geographical Changes 2Health News:Autoimmune disorders studied in detail by U-M researchers. 2Health News:India Approves Baraclude? (entecavir) For ,Treatment Of Chronic HEPATITIS B 2
(Date:11/25/2009)...a-FirstCall/--ChinaSkyOne,Medical,Inc.("ChinaSkyOn...ullyintegratedpharmaceuticalcompanydevelopingandpr...ofChina("PRC"),today,announcedthattheCompanyrecent...fPharmaceuticalandBiologicalProducts("ICPBP")exami...umanProstateSpecific,Antigen(ColloidalGold)anditsD...
(Date:11/25/2009)...AccordingtoMillenniumResearchGroup(MRG),theglobala...early$3billionUSmarketfortraumafixationdeviceswill...etherecenteconomicslowdown.MRG,s USMarketsforTraum...highlydynamicoverthenextfiveyears,withcompetitorsi...dsegmentsofthetraumafixationmarket,fuelingmarketgr...
(Date:11/25/2009)...G,November25/PRNewswire/--,iThembaPharmaceuticals,...ttheyhavesignedacollaborativeagreementtojointlymar...sscomputationalchemistryandleaddiscoveryexpertise,...medicinaland,syntheticchemistrysupporttoprojectsid...ThembaPharmaceuticalsandPyxisDiscovery,alsoannounc...
Breaking Medicine Technology:China Sky One Medical, Inc. Achieved Progress in the Development of Two New Biological Testing Kits 2China Sky One Medical, Inc. Achieved Progress in the Development of Two New Biological Testing Kits 3US Trauma Fixation Device Market Not Seeing Signs of Slowdown 2US Trauma Fixation Device Market Not Seeing Signs of Slowdown 3iThemba Pharmaceuticals (Pty) Ltd and Pyxis Discovery B.V. Announce Collaborative Agreement to Offer a Combined Service Offering 2AUDIO from Medialink and Guardian 3A Breast Cancer Awareness Month Highlights Need for Critical Illness Insurance 59684 1International SOS Awarded TRICARE Overseas Program Contract 59681 1International SOS Awarded TRICARE Overseas Program Contract 59681 2FDA Approves Elitek 28R 29 28rasburicase 29 for Management of Plasma Uric Acid Levels in Adults with Leukemia Lymphoma and Solid Tumors Receiving A 5545 1FDA Approves Elitek 28R 29 28rasburicase 29 for Management of Plasma Uric Acid Levels in Adults with Leukemia Lymphoma and Solid Tumors Receiving A 5545 2FDA Approves Elitek 28R 29 28rasburicase 29 for Management of Plasma Uric Acid Levels in Adults with Leukemia Lymphoma and Solid Tumors Receiving A 5545 3FDA Approves Elitek 28R 29 28rasburicase 29 for Management of Plasma Uric Acid Levels in Adults with Leukemia Lymphoma and Solid Tumors Receiving A 5545 4FDA Approves Elitek 28R 29 28rasburicase 29 for Management of Plasma Uric Acid Levels in Adults with Leukemia Lymphoma and Solid Tumors Receiving A 5545 5FDA Approves Elitek 28R 29 28rasburicase 29 for Management of Plasma Uric Acid Levels in Adults with Leukemia Lymphoma and Solid Tumors Receiving A 5545 6FDA Approves Elitek 28R 29 28rasburicase 29 for Management of Plasma Uric Acid Levels in Adults with Leukemia Lymphoma and Solid Tumors Receiving A 5545 7
...IRE)--Jun 13, 2007 - EPIX,Pharmaceuticals, Inc. (N...ase 3 trial of PRX-00023, a novel long-acting 5-HT...at the 47th Annual New,Clinical Drug Evaluation Un...ting is sponsored by the National Institutes of,He...armacology., The presentation highlighted data fro...
..., WA -- (MARKET WIRE) -- June 14,2007 -- Targeted...rting data from the dose escalation arm of the ong...nts with inflammatory,arthritis. Philip J. Mease, ...ington School of Medicine, chief of rheumatology,c...acticing,physician with Seattle Rheumatology Assoc...
Other Medicine Technology:EPIX Pharmaceuticals Presents Findings from PRX-00023 Phase 3,Clinical Trial at 47th Annual NCDEU Meeting 2EPIX Pharmaceuticals Presents Findings from PRX-00023 Phase 3,Clinical Trial at 47th Annual NCDEU Meeting 3EPIX Pharmaceuticals Presents Findings from PRX-00023 Phase 3,Clinical Trial at 47th Annual NCDEU Meeting 4Targeted Genetics Reports Inflammatory Arthritis Clinical Data at,European Rheumatology Conference 2Targeted Genetics Reports Inflammatory Arthritis Clinical Data at,European Rheumatology Conference 3Targeted Genetics Reports Inflammatory Arthritis Clinical Data at,European Rheumatology Conference 4Targeted Genetics Reports Inflammatory Arthritis Clinical Data at,European Rheumatology Conference 5Targeted Genetics Reports Inflammatory Arthritis Clinical Data at,European Rheumatology Conference 6
Anti-MPO - ELISA (P-ANCA)
Myeloperoxidase (MPO) Enzyme-Linked Immunosorbent Assay (ELISA)
Iso-Insulin ELISA
RIDASCREEN Anti-RSV IgM Assay
Medicine Products: